Progress in the fight for Hepatitis C elimination
The momentum gained in tackling Hepatitis C before COVID-19, should not – and need not – be lost, says Professor Steve Ryder. He provides an insight into the latest developments in the fight to eliminate Hepatitis C and issues a call to action.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
Kimal is an innovative manufacturer of customised procedure packs and vascular access devices, to clinical departments in over 70 countries worldwide. The company manufactures over 2 million procedure packs and vascular access devices every year for a range of specialities.